Imcivree side effects, by duration, gender and age (a phase IV clinical study of FDA data)

female:

1. Abdominal pain
2. Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
3. Skin hyperpigmentation (disorders affect the colour of your skin)
4. Ankle fracture
5. Ephelides (tanned macules found on the skin)
6. Asthenia (weakness)
7. Diarrhoea
8. Nausea (feeling of having an urge to vomit)
9. Abdominal pain upper
10. Affect lability (emotional incontinence)

male:

1. Abdominal pain
2. Abdominal discomfort
3. Chills (felling of cold)
4. Decreased appetite
5. Diarrhoea
6. Drug ineffective
7. Hand-foot-and-mouth disease
8. Hunger
9. Injection site reaction
10. Staphylococcal infection (an infection with staphylococcus bacteria)

0-1:

n/a

2-9:

1. Abdominal pain
2. Abdominal pain upper
3. Asthenia (weakness)
4. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
5. Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
6. Abdominal discomfort
7. Anger
8. Ephelides (tanned macules found on the skin)
9. Hand-foot-and-mouth disease
10. Pneumonia

10-19:

1. Abdominal pain
2. Diarrhoea
3. Drug ineffective
4. Headache (pain in head)
5. Nausea (feeling of having an urge to vomit)
6. Abdominal discomfort
7. Affect lability (emotional incontinence)
8. Aggression
9. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
10. Apathy

20-29:

1. Chills (felling of cold)
2. Flushing (the warm, red condition of human skin)
3. Hyperphagia (an abnormal appetite for food)
4. Skin hyperpigmentation (disorders affect the colour of your skin)

30-39:

1. Ankle fracture
2. Anaphylactic reaction (serious allergic reaction)
3. Depression
4. Alanine aminotransferase increased
5. Arthralgia (joint pain)
6. Asthenia (weakness)
7. Staphylococcal infection (an infection with staphylococcus bacteria)

40-49:

1. Appendicitis (inflammation of the appendix)
2. Cough
3. Decreased appetite
4. Skin discolouration (change of skin colour)

50-59:

1. Injection site bruising

60+:

1. Abdominal pain
2. Ephelides (tanned macules found on the skin)

< 1 month:

1. Abdominal pain
2. Abdominal discomfort
3. Abdominal pain upper
4. Affect lability (emotional incontinence)
5. Alanine aminotransferase increased
6. Decreased appetite
7. Injection site reaction
8. Nausea (feeling of having an urge to vomit)

1 - 6 months:

1. Asthenia (weakness)
2. Abdominal pain

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Skin hyperpigmentation (disorders affect the colour of your skin)
2. Diarrhoea
3. Abdominal pain
4. Melanocytic naevus (a type of lesion that contains nevus cells (a type of melanocyte))
5. Ankle fracture
6. Depression
7. Drug ineffective
8. Ephelides (tanned macules found on the skin)
9. Anaphylactic reaction (serious allergic reaction)
10. Asthenia (weakness)